Pete Badian

“Just one question, just a deep dive, please, Vaz, on H.S. Could you perhaps, you talked about MBRX during the presentation, but could you talk about current volume price dynamics for Cosentix in H.S., the target clinical profile for Rapsido in H.S., and how, if the data's positive, you would intend to position both…”